PureTech Health PLC
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. The co… Read more
PureTech Health PLC (PRTC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.126x
Based on the latest financial reports, PureTech Health PLC (PRTC) has a cash flow conversion efficiency ratio of -0.126x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-46.34 Million) by net assets ($369.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
PureTech Health PLC - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how PureTech Health PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
PureTech Health PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PureTech Health PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cloetta AB ser. B
PINK:CLOEF
|
0.075x |
|
Guzman Y GOMEZ Ltd
AU:GYG
|
0.119x |
|
Haoxiangni Jujube Co Ltd
SHE:002582
|
0.029x |
|
LINK Mobility Group Holding ASA
PINK:LMGHF
|
0.041x |
|
Performant Healthcare, Inc
NASDAQ:PHLT
|
0.005x |
|
Intralot S.A. Integrated Lottery Systems and Services
PINK:IRLTF
|
0.306x |
|
Minto Apartment Real Estate Investment Trust
TO:MI-UN
|
0.017x |
|
Fuchun Technology Co Ltd
SHE:300299
|
-0.037x |
Annual Cash Flow Conversion Efficiency for PureTech Health PLC (2012–2024)
The table below shows the annual cash flow conversion efficiency of PureTech Health PLC from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $407.93 Million | $-134.37 Million | -0.329x | -42.50% |
| 2023-12-31 | $458.23 Million | $-105.92 Million | -0.231x | +29.21% |
| 2022-12-31 | $547.59 Million | $-178.79 Million | -0.327x | -20.51% |
| 2021-12-31 | $584.15 Million | $-158.27 Million | -0.271x | -34.32% |
| 2020-12-31 | $653.54 Million | $-131.83 Million | -0.202x | -33.66% |
| 2019-12-31 | $650.40 Million | $-98.16 Million | -0.151x | +65.38% |
| 2018-12-31 | $166.97 Million | $-72.80 Million | -0.436x | +68.54% |
| 2017-12-31 | $64.00 Million | $-88.69 Million | -1.386x | -120.68% |
| 2016-12-31 | $92.41 Million | $-58.03 Million | -0.628x | -260.08% |
| 2015-12-31 | $164.05 Million | $-28.61 Million | -0.174x | -121.14% |
| 2014-12-31 | $133.69 Million | $-10.54 Million | -0.079x | -107.21% |
| 2013-12-31 | $-8.03 Million | $-8.77 Million | 1.093x | +152.49% |
| 2012-12-31 | $-3.35 Million | $-1.45 Million | 0.433x | -- |